113 related articles for article (PubMed ID: 37611664)
1. Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice.
Arakawa H; Kawanishi T; Shengyu D; Nishiuchi T; Meguro-Horike M; Horike SI; Sugimoto M; Kato Y
J Pharm Sci; 2023 Dec; 112(12):3209-3215. PubMed ID: 37611664
[TBL] [Abstract][Full Text] [Related]
2. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis.
Slitt AL; Allen K; Morrone J; Aleksunes LM; Chen C; Maher JM; Manautou JE; Cherrington NJ; Klaassen CD
Biochim Biophys Acta; 2007 Mar; 1768(3):637-47. PubMed ID: 17141734
[TBL] [Abstract][Full Text] [Related]
3. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
[TBL] [Abstract][Full Text] [Related]
4. Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib.
Kawanishi T; Arakawa H; Masuo Y; Nakamichi N; Kato Y
J Pharm Sci; 2019 Sep; 108(9):3130-3137. PubMed ID: 31136764
[TBL] [Abstract][Full Text] [Related]
5. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
[TBL] [Abstract][Full Text] [Related]
7. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats.
Villanueva SS; Ruiz ML; Soroka CJ; Cai SY; Luquita MG; Torres AM; Sánchez Pozzi EJ; Pellegrino JM; Boyer JL; Catania VA; Mottino AD
Drug Metab Dispos; 2006 Aug; 34(8):1301-9. PubMed ID: 16679389
[TBL] [Abstract][Full Text] [Related]
10. Role of breast cancer resistance protein in the adaptive response to cholestasis.
Mennone A; Soroka CJ; Harry KM; Boyer JL
Drug Metab Dispos; 2010 Oct; 38(10):1673-8. PubMed ID: 20601550
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.
López-Sánchez LM; Corrales FJ; Barcos M; Espejo I; Muñoz-Castañeda JR; Rodríguez-Ariza A
Lab Invest; 2010 Jan; 90(1):116-27. PubMed ID: 19806079
[TBL] [Abstract][Full Text] [Related]
12. Impairment of bilirubin clearance and intestinal interleukin-6 expression in bile duct-ligated vitamin D receptor null mice.
Ishizawa M; Ogura M; Kato S; Makishima M
PLoS One; 2012; 7(12):e51664. PubMed ID: 23240054
[TBL] [Abstract][Full Text] [Related]
13. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
[TBL] [Abstract][Full Text] [Related]
14. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
[TBL] [Abstract][Full Text] [Related]
15. Increase in renal glutathione in cholestatic liver disease is due to a direct effect of bile acids.
Purucker E; Marschall HU; Geier A; Gartung C; Matern S
Am J Physiol Renal Physiol; 2002 Dec; 283(6):F1281-9. PubMed ID: 12388394
[TBL] [Abstract][Full Text] [Related]
16. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotection in bile duct ligated mice mediated by darbepoetin-α is not caused by changes in hepatobiliary transporter expression.
Eipel C; Menschikow E; Sigal M; Kuhla A; Abshagen K; Vollmar B
Int J Clin Exp Pathol; 2013; 6(1):80-90. PubMed ID: 23236546
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
19. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6.
Maher JM; Cherrington NJ; Slitt AL; Klaassen CD
Life Sci; 2006 Apr; 78(19):2219-25. PubMed ID: 16260000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
